Psychiatr. praxi. 2020;21(3):120-123 | DOI: 10.36290/psy.2020.021
Drug interactions - experience with the software assistant
- 1 Oddělení psychiatrické, Fakultní nemocnice Ostrava
- 2 Katedra neurologie a psychiatrie, Lékařská fakulta, Ostravská univerzita
Considering the high prevalence of combinations of both psychiatric and somatic drugs, drug interactions represent atopical issue in psychiatry. We performed the analysis of the computer program records and we have defined 15 most often reported interactions of the highest importance. Our survey contains 6 antidepressants, 4 antipsychotics, 2 sedatives/hypnotics and 1 drug used in atreatment of addiction. Athreat in aparticular patient depends on additional risk factors and individual adverse events are of different seriousness and they are recognizable differently. Aclinician is obliged to assess the information of acomputer system critically. The awareness, i.e. anticipating of drug interactions is the most important in our opinion. So we emphasize the usefulness of routine usage of asoftware assistant.
Keywords: electronic support of prescription, drug interactions, antidepressants, antipsychotics, QTc interval prolongation.
Published: December 10, 2020 Show citation
References
- Suchopár J, Prokeš M, Suchopár O. Spotřeba antidepresiv v České republice ve srovnání s ostatními vyspělými zeměmi. Remedia 2016; 26(6): 560-562.
- Wong J, Motulsky A, Abrahamowicz M, Eguale T, Buckeridge DL, Tamblyn R. Off‑label Indications for Antidepressants in Primary Care: Descriptive Study of Prescriptions from an Indication Based Electronic Prescribing System. BMJ 2017, 356: j603.
Go to original source... 
Go to PubMed... - Prokeš M, Suchopár J. Lékové interakce často předepisovaných antidepresiv. Klin. Farmakol. Farm 2019; 33(2): 36-43. Go to original source...
- Stahl SM. Stahl's Essential Psychopharmacology. 4th ed. Cambridge: Cambridge University Press 2013; 608 pp.
- SPC Cordarone; dostupné na: www.sukl.cz
- SPC Neurol; dostupné na: www.sukl.cz
- Wenzel‑Seifert K, Wittmann M, Haen E. QTc Prolongation by Psychotropic Drugs and the Risk of Torsade de Pointes. Dtsch Arztebl Int 2011; 108(41): 687-693. Go to original source... Go to PubMed...
- Beach SR, Celano CM, Noseworthy PA, Januzzi JL, Huffman JC. QTc Prolongation, Torsades de Pointes, and Psychotropic Medications. Psychosomatics 2013; 54: 1-13. Go to original source... Go to PubMed...
- Prokeš M, Suchopár J. Vzácné nežádoucí příhody u léků užívaných v psychiatrii: Serotoninový syndrom a arytmie torsade de pointes. Psychiatr. praxi 2015; 16(3): 84-88.
- Bleakley S. Antidepressant drug interactions: evidence and clinical significance. Progress in Neurology and Psychiatry. 2016; May/June: 21-27. Go to original source...